CTLA4 and neoplasm: The association with IGSF8 may support immune cell recruitment and activation at inflammatory or tumor sites, whereas negative associations with CTLA4 and TIGIT imply a counter-regulatory effect on checkpoint pathways, potentially strengthening T-cell-mediated anti-tumor responses.